Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Screening Contrast-Enhanced Mammography as an Alternative to MRI
NCT04764292Phase 4Completed
- Start
- Feb 2021
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial. Primary endpoint: Cancer Detection Rate at 1.5 years. Started Feb 2021; status: completed.
Beyond the preview
Go deeper on NCT04764292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04764292.